Mobile

A clinical study involving children up to age of 12 years with severe hemophilia A, to look at how safe an experimental replacement factor VIII protein (known as rFVIIIFc) is to take and how well it w...

Mise à jour : Il y a 5 ans
Référence : EUCTR2011-003073-28

A clinical study involving children up to age of 12 years with severe hemophilia A, to look at how safe an experimental replacement factor VIII protein (known as rFVIIIFc) is to take and how well it works to prevent and stop bleeds

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary objective of the study is to evaluate safety of rFVIIIFc in previously treated pediatric subjects with hemophilia A.

Critère d'inclusion

  • Severe Hemophilia A

Liens